Theater Mitu to Open New Gowanus Space With World Premiere of Remnant

Off-Broadway News   Theater Mitu to Open New Gowanus Space With World Premiere of Remnant
 
The company's newest project is part performance, part art installation, created from three years of research and interviews.
Remnant Key Art HR

Theater Mitu, the company behind last season's hyper-theatrical Death of a Salesman at BAM, will celebrate the opening of its brand-new performance space in Gowanus, Brooklyn, with the world premiere of Remnant. The new show combines audio interviews with performance, found text, technology, and images, to investigate how loss, grief, and death inform the lives and choices of those who are left behind.

For the past three years, members of Theater Mitu have been conducting interviews with people from all walks of life and from various types of communities who have experienced some profound form of loss. Performers in the show—part performance, part visual art installation—will act as dispatchers of image and voice.

Remnant is directed by Theater Mitu Founding Artistic Director Rubén Polendo (also chair of Tisch’s Under-Graduate Drama at NYU). Performances will begin August 24 at 580 Sackett St, Brooklyn, and are scheduled through September 14.

The new work is created by collaborating artists Polendo, Justin Nestor, Denis Butkus, Michael Littig, Scott Spahr, Corey Sullivan, Ada Westfall, Kayla Asbell, Attilio Rigotti, Alex Hawthorn, and Xiao Quan.

After a seven-year residency at the NYU Abu Dhabi Arts Center in the Middle East, Theater Mitu has transformed an old warehouse in Gowanus into a new multi-use arts space performance venue. Remnant is the space's inaugural production.

For tickets and more information on Remnant, visit TheaterMitu.org.

Click Here to Shop for Theatre
Merchandise in the Playbill Store
 
Latest News
 X

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!